Last reviewed · How we verify

NCT05996861

Protocol For Sleep for Critically Ill Patients

Status unknown Last updated 18 August 2023
What this trial tests

trial testing ICU sleep protocol in Sleep Disorders in 100 participants. Status unknown.

Timeline
20 March 2023
Primary endpoint
30 November 2023
1 June 2024

Quick facts

Lead sponsorHospital Moinhos de Vento
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date20 March 2023
Primary completion30 November 2023
Estimated completion1 June 2024
Sites2 locations across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Moinhos de Vento

Who can join

18 and older, any sex, with Sleep Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sleep is essential for health and well-being. The quality of sleep impacts physical and cognitive aspects, including memory, immune system, and neuroendocrine function, with abnormalities associated with cardiovascular changes, neuropsychiatric disorders, and mortality. Additionally, sleep disorders are related to an increased incidence of delirium in Intensive Care Units (ICUs). Routines to control environmental factors in ICUs seem to have an impact on reducing the incidence of acute brain dysfunction - delirium - and could help prevent sleep disturbances in critically ill patients. This study aims to demonstrate an improvement in sleep quality in critically ill patients through the reduction of the Richards-Campbell Sleep Questionnaire score and propose a package of measures to improve sleep practices in ICU-admitted patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sleep Disorders

Currently open trials in the same condition.

Other Hospital Moinhos de Vento trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05996861.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing